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P1084. Alzheimer’s Disease and the cystatin c gene 
polymorphism: an association study.
R. Cittadella1, F. Condino1, N. Romeo1, G. Nicoletti1,2, V. Andreoli1;  
1Istituto di Scienze Neurologiche, Pianolago di Mangone (CS), Italy, 22 Institute 
of Neurology, University Magna Graecia, Catanzaro, Italy.
Cystatin C is a cysteine protease inhibitor which is found to colocalize 
with Aβ in plaques and cerebrovascular deposits in Alzheimer’s 
Disease (AD) . Recent studies have reported a genetic association 
between the 73 G/A polymorphism within exon 1 of the cystatin C 
gene (CST3), a common Ala/Thr substitution in the signal peptide, and 
Alzheimer’s disease (AD) with conflicting results. To further investigate 
the proposed association in our population, we analyzed this variant 
in a clinic and population based group of 171 Italian patients with 
sporadic AD from southern Italy (Calabria region) and 190 healthy 
controls subjects from the same geographical area . All 361 subjects 
were genotyped for CST3 and APOE polymorphisms but our data 
showed no association between AD and CST3. We therefore stratified 
our samples based on age (of controls) or age of onset (of cases): <65-
69, 70-79, and 80+ years. After this stratification according to age, in 
older patients (80+ years) the GG frequency resulted over-represented 
when compared to controls, but far from statistically significant. There 
was also no evidence of a statistical interaction between CST3 and 
APOE polymorphisms . In conclusion, our data suggest that the 73 G/A 
polymorphism within exon 1 of the cystatin C gene is not a susceptibility 
factor in AD and nor mitigate the effect of the ApoE -ε 4 allele in the risk 
of developing AD in our population but further studies will be necessary 
to clarify the CST3 polymorphism position among AD risk factors .
P1085. two sNPs in the Fas gene on chromosome 10 are not 
associated with italian sporadic Alzheimer‘s Disease
V. Andreoli1, L. Nicoletti1, F. Trecroci1, F. Condino1, N. Romeo1, G. Nicoletti1,2, 
R. Cittadella1;  
1Istituto di Scienze Neurologiche, Pianolago di Mangone (CS), Italy, 22 Institute 
of Neurology, University Magna Graecia, Catanzaro, Italy.
The TNFRSF6 (Tumor Necrosis Factor Receptor Super Family 6) 
gene encodes Fas antigen, a cell surface receptor-mediating cell 
apoptosis situated on chromosome 10q, near the region of linkage to 
sporadic Alzheimer’s Disease (AD) . Moreover, elevated levels of Fas 
have reported in the brain of AD patients . These two criteria, positional 
and pathobiological, make the Fas antigen an interesting candidate 
for an association with AD. To address these findings, we have tested 
two SNPs in the TNFRSF6 gene in a set of 223 Italian patients with 
non-familial (sporadic) AD from southern Italy and 211 healthy controls 
subjects: a G to A polymorphism at position (-670) in the enhancer 
region of the promoter and a single nucleotide change from C to T 
74 nucleotides from the beginning of exon 7 in the Fas gene . There 
was no statistically significant differences in allelic and genotypic 
frequency distribution between cases and controls or between late 
and early-onset AD patients . No interactive effect was found between 
the Fas polymorphisms and the known risk factor of non-familial AD, 
Apolipoprotein-E ε4 allele. We also tested whether these different 
Fas genotypes were associated with clinical features, such as age at 
disease onset and disease progression but no significant differences 
was detected . The present data suggest that the polymorphisms do 
not represent a risk factor for AD in our population .
P1086. Effect of Apolipoprotein E (APOE) genotype and past 
fertility on age of onset of Alzheimer’s disease in women
R. M. Corbo1, L. Ulizzi1, G. Gambina2, E. Broggio2, G. Moretto2, R. Scacchi3;  
1University La Sapienza, Rome, Italy, 2Verona Hospital, Verona, Italy, 3CNR 
Institute of molecular biology and pathology, Rome, Italy.
Various genetic and non-genetic risk factors have been linked to 
the development of Alzheimer’s disease (AD) . In women, having 
had children is one of the non-genetic factors reportedly associated 
with an increased risk of AD . Among genetic factors involved in AD 
susceptibility, the APOE e*4 allele has a major role and its presence 
reduces age at AD onset. But APOE is also thought to influence 
human reproduction as well, and common APOE genotypes seem to 
be associated with differential fertility . With this study, we investigated 
possible relationships between APOE genotype, past fertility, and AD 
onset age in a sample of 116 women with the sporadic form of the 
disease . Results from a comparison of APOE genotype distribution 
in parous and nulliparous AD women supported previous findings 
indicating that the e*3/e*3 genotype was associated with higher 
fertility and the e*4 carrying genotypes with lower fertility . When the 
combined effects of fertility and APOE genotypes on AD onset age 
were analysed parity was found to be associated with a significantly 
lower AD onset age ( 72.3±5.9 years) than nulliparity (79.0±5.6 years; 
P=0 .004) among e*3/e*3 homozygotes . Since e*3/e*3 is the most 
frequent APOE genotype in Europe (0 . 56--0 .70), past fertility may 
influence AD susceptibility in many women. A similar effect was absent 
among e*4 carriers. Our findings indicate that past fertility may have 
a relevant effect on AD onset age and that the effect is mediated by 
APOE genotype .
P1087. complex haplotypes from apo(a) gene locus control 
regions and correlation to Lp(a) plasma levels
K. Zidkova1,2, V. Kebrdlova2, L. Zlatohlavek1, R. Ceska1;  
13rd Medical Department, 1st Faculty of Medicine and General Teaching Hospi-
tal, Charles University in Prague, Prague, Czech Republic, 2Institute of Biology 
and Medical Genetics, 1st Faculty of Medicine, Charles University in Prague, 
Prague, Czech Republic.
Objectives: High lipoprotein(a), Lp(a), level is an independent risk factor 
for developement of premature atherosclerosis . Apolipoprotein(a), 
apo(a), is the main determinant of Lp(a) plasma concentration . The aim 
of our study was to reconstruct haplotypes using five polymorphisms 
from the apo(a) gene regulatory sequences (promoter, DHIII enhancer) 
and to compare their distribution in five groups of individuals with 
different range of Lp(a) level and in a population sample .
methods: The out-patients pool of the 3rd Medical Department was 
divided into quintiles according to Lp(a) concentration . Population 
sample was derived from the Institute of Biology and Medical Genetics . 
Three polymorphisms (TTTTAn repetition, +93C/T, +121G/A) from the 
apo(a) gene promoter and two polymorphisms (-1617C/A, -1230A/G) 
from the DHIII enhancer region were detected by the fragmentation 
analysis (TTTTAn repetition ) and by the DGGE method in combination 
with sequencing in the quintiles and by the RFLP and allele-specifice 
PCR in the population sample .
Results: From the 80 possible haplotypes 23 were able to bulit up all 
observed genotypes in the quintiles and population sample . Several 
statistically significant differences were observed in frequencies 
distribution among quintiles and between each quintile and population 
sample . Some of the haplotypes were isolated to a narrow range of 
Lp(a) levels .
conclusion: We conclude from our study that complex haplotypes 
from apo(a) gene locus could be used as a marker for certain range of 
apo(a) gene length variants and thus Lp(a) levels .
This study was supported by grant IGAMZCR NR-8328-3/200 and by 
MSM0021620807.
P1088. Polymorphism of the ApoE locus in the Azores islands 
(Portugal)
C. Bettencourt1, R. Montiel1, C. Santos1, M. Pavão1, A. Viegas-Crespo2, P. 
Lopes2, M. Lima1;  
1University of the Azores, Ponta Delgada - Azores, Portugal, 2University of Lis-
bon, Lisbon, Portugal.
The aim of this work was to report on the polymorphism of the ApoE 
locus in the Azores Islands (Portugal) in order to get insights on the 
genetic background that influences the lipid profile in this population, 
ascertained as considerably high in a preliminary study of a sample 
of healthy subjects (60% of individuals were hypercholesterolemics) . 
One hundred and twenty six Azorean individuals were typed for ApoE 
polymorphism using standard PCR-RFLP . The allelic frequencies 
obtained for ε2, ε3 and ε4 were 6.75%, 83.73% and 9.52%, 
respectively . Genotypic frequencies were in conformity with Hardy-
Weinberg expectations. The ε3/ε3 genotype presented the highest 
frequency (69.84%), whilst ε4/ε4 was the least frequent (0.79%). 
The genotypic and allelic frequencies observed were similar to those 
reported for other Iberian samples . Furthermore, Nei’s gene diversity 
(0 .2864±0 .0351) was similar to the reported for samples from Mainland 
Portugal . Results obtained did not evidence a particular behaviour of 
the ApoE locus that could be directly related with the high levels of total 
cholesterol determined in the Azorean population .
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